| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 5.19e-05 | 26 | 56 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 2.07e-04 | 41 | 56 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 2.75e-04 | 9 | 56 | 2 | GO:0016308 | |
| GeneOntologyCellularComponent | CKM complex | 9.46e-05 | 5 | 65 | 2 | GO:1990508 | |
| Domain | NBPF_dom | 2.72e-08 | 11 | 58 | 4 | IPR010630 | |
| Domain | NBPF | 2.72e-08 | 11 | 58 | 4 | PS51316 | |
| Domain | DUF1220 | 2.72e-08 | 11 | 58 | 4 | PF06758 | |
| Domain | DUF1220 | 2.36e-06 | 9 | 58 | 3 | SM01148 | |
| Domain | PInositol-4-P-5-kinase | 1.97e-04 | 7 | 58 | 2 | IPR023610 | |
| Domain | PIPKc | 2.62e-04 | 8 | 58 | 2 | SM00330 | |
| Domain | - | 2.62e-04 | 8 | 58 | 2 | 3.30.800.10 | |
| Domain | PIP5K | 2.62e-04 | 8 | 58 | 2 | PF01504 | |
| Domain | PIPK | 2.62e-04 | 8 | 58 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 2.62e-04 | 8 | 58 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 2.62e-04 | 8 | 58 | 2 | IPR027483 | |
| Domain | - | 2.62e-04 | 8 | 58 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 2.62e-04 | 8 | 58 | 2 | IPR002498 | |
| Domain | Haem_peroxidase | 4.20e-04 | 10 | 58 | 2 | IPR010255 | |
| Domain | An_peroxidase | 4.20e-04 | 10 | 58 | 2 | PF03098 | |
| Domain | PEROXIDASE_3 | 4.20e-04 | 10 | 58 | 2 | PS50292 | |
| Domain | Haem_peroxidase_animal | 4.20e-04 | 10 | 58 | 2 | IPR019791 | |
| Domain | - | 4.20e-04 | 10 | 58 | 2 | 1.10.640.10 | |
| Domain | CUB | 4.73e-04 | 49 | 58 | 3 | PF00431 | |
| Domain | CUB | 5.02e-04 | 50 | 58 | 3 | SM00042 | |
| Domain | - | 5.64e-04 | 52 | 58 | 3 | 2.60.120.290 | |
| Domain | Sushi | 5.64e-04 | 52 | 58 | 3 | PF00084 | |
| Domain | CUB | 5.96e-04 | 53 | 58 | 3 | PS01180 | |
| Domain | CCP | 6.30e-04 | 54 | 58 | 3 | SM00032 | |
| Domain | SUSHI | 7.01e-04 | 56 | 58 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 7.38e-04 | 57 | 58 | 3 | IPR000436 | |
| Domain | CUB_dom | 7.38e-04 | 57 | 58 | 3 | IPR000859 | |
| Domain | PRAME_family | 1.57e-03 | 19 | 58 | 2 | IPR026271 | |
| Domain | EGF | 6.09e-03 | 235 | 58 | 4 | SM00181 | |
| Domain | EGF | 7.06e-03 | 126 | 58 | 3 | PF00008 | |
| Domain | EGF-like_dom | 7.45e-03 | 249 | 58 | 4 | IPR000742 | |
| Domain | EGF-like_CS | 8.76e-03 | 261 | 58 | 4 | IPR013032 | |
| Domain | EGF_2 | 9.23e-03 | 265 | 58 | 4 | PS01186 | |
| Pathway | REACTOME_PI_METABOLISM | 8.64e-05 | 77 | 43 | 4 | MM14590 | |
| Pathway | REACTOME_PI_METABOLISM | 1.21e-04 | 84 | 43 | 4 | M676 | |
| Pubmed | NBPF8 NBPF19 NBPF15 NBPF12 NBPF9 NBPF10 NBPF11 NBPF14 NBPF20 | 6.02e-20 | 21 | 67 | 9 | 16079250 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 5.70e-12 | 10 | 67 | 5 | 22973535 | |
| Pubmed | Lineage-specific gene duplication and loss in human and great ape evolution. | 2.33e-07 | 69 | 67 | 5 | 15252450 | |
| Pubmed | 6.17e-07 | 513 | 67 | 9 | 25798074 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 9.73e-07 | 170 | 67 | 6 | 23314748 | |
| Pubmed | Structures of mouse DUOX1-DUOXA1 provide mechanistic insights into enzyme activation and regulation. | 3.66e-06 | 2 | 67 | 2 | 32929281 | |
| Pubmed | PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway. | 3.66e-06 | 2 | 67 | 2 | 18073347 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 12682053 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 11493482 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 21813447 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 23999921 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 32376619 | ||
| Pubmed | Structures of human dual oxidase 1 complex in low-calcium and high-calcium states. | 3.66e-06 | 2 | 67 | 2 | 33420071 | |
| Pubmed | Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis. | 3.66e-06 | 2 | 67 | 2 | 19153220 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 31550809 | ||
| Pubmed | Type I phosphotidylinosotol 4-phosphate 5-kinase γ regulates osteoclasts in a bifunctional manner. | 3.66e-06 | 2 | 67 | 2 | 23300084 | |
| Pubmed | Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia. | 3.66e-06 | 2 | 67 | 2 | 12931227 | |
| Pubmed | NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. | 3.66e-06 | 2 | 67 | 2 | 17589499 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 28776436 | ||
| Pubmed | PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions. | 3.66e-06 | 2 | 67 | 2 | 19889969 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 27870828 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 18042078 | ||
| Pubmed | Epidermal growth factor-induced hydrogen peroxide production is mediated by dual oxidase 1. | 1.10e-05 | 3 | 67 | 2 | 27262981 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 14681219 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 25145343 | ||
| Pubmed | CLIC1 recruits PIP5K1A/C to induce cell-matrix adhesions for tumor metastasis. | 1.10e-05 | 3 | 67 | 2 | 33079727 | |
| Pubmed | Dual oxidase regulates neutrophil recruitment in allergic airways. | 1.10e-05 | 3 | 67 | 2 | 23770197 | |
| Pubmed | TNFR1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine. | 1.10e-05 | 3 | 67 | 2 | 14525729 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 24951466 | ||
| Pubmed | PIP5KIβ selectively modulates apical endocytosis in polarized renal epithelial cells. | 1.10e-05 | 3 | 67 | 2 | 23342003 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 22942276 | ||
| Pubmed | NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia. | 1.10e-05 | 3 | 67 | 2 | 37147424 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 18188447 | ||
| Pubmed | Identification and characterization of a phosphoinositide phosphate kinase homolog. | 2.19e-05 | 4 | 67 | 2 | 14701839 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 19047373 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 9535851 | ||
| Pubmed | The type of DUOX-dependent ROS production is dictated by defined sequences in DUOXA. | 2.19e-05 | 4 | 67 | 2 | 22814254 | |
| Pubmed | Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells. | 2.19e-05 | 4 | 67 | 2 | 19339556 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | NBPF15 PRAMEF25 PRAMEF20 NBPF10 PIP5K1A NBPF11 TNFRSF1B CSMD2 PTGS2 EPHA8 | 2.69e-05 | 1031 | 67 | 10 | 16710414 |
| Pubmed | The lipid kinase PIP5K1C regulates pain signaling and sensitization. | 3.64e-05 | 5 | 67 | 2 | 24853942 | |
| Pubmed | 4.28e-05 | 35 | 67 | 3 | 15031101 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PNPLA6 BCAS3 PI4KA NSD1 PLXND1 GPC2 PIP5K1C ST14 MED13 ABCC10 | 4.83e-05 | 1105 | 67 | 10 | 35748872 |
| Pubmed | Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1. | 5.46e-05 | 6 | 67 | 2 | 14614850 | |
| Pubmed | 5.46e-05 | 6 | 67 | 2 | 28581524 | ||
| Pubmed | 5.46e-05 | 6 | 67 | 2 | 20841379 | ||
| Pubmed | 5.46e-05 | 6 | 67 | 2 | 15123724 | ||
| Pubmed | 7.63e-05 | 7 | 67 | 2 | 15018809 | ||
| Pubmed | The Cdk8/19-cyclin C transcription regulator functions in genome replication through metazoan Sld7. | 1.02e-04 | 8 | 67 | 2 | 30695077 | |
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 15046600 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 20622009 | ||
| Pubmed | 1.30e-04 | 9 | 67 | 2 | 22976293 | ||
| Pubmed | 1.30e-04 | 9 | 67 | 2 | 20233719 | ||
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 1.63e-04 | 10 | 67 | 2 | 23746844 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.82e-04 | 430 | 67 | 6 | 35044719 | |
| Pubmed | 1.99e-04 | 11 | 67 | 2 | 16602701 | ||
| Pubmed | 2.27e-04 | 1084 | 67 | 9 | 11544199 | ||
| Pubmed | 2.38e-04 | 12 | 67 | 2 | 23563140 | ||
| Pubmed | CDK8 is a positive regulator of transcriptional elongation within the serum response network. | 2.81e-04 | 13 | 67 | 2 | 20098423 | |
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 27570068 | ||
| Pubmed | A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation. | 3.28e-04 | 14 | 67 | 2 | 10024883 | |
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 16517735 | ||
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 10882111 | ||
| Pubmed | Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. | 4.88e-04 | 17 | 67 | 2 | 10235266 | |
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 10198638 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 5.79e-04 | 197 | 67 | 4 | 29872149 | |
| Pubmed | 6.79e-04 | 20 | 67 | 2 | 15340084 | ||
| Pubmed | 7.22e-04 | 209 | 67 | 4 | 26389662 | ||
| Pubmed | 8.21e-04 | 378 | 67 | 5 | 34315543 | ||
| Pubmed | 8.24e-04 | 22 | 67 | 2 | 11867769 | ||
| Pubmed | 8.24e-04 | 22 | 67 | 2 | 23975195 | ||
| Pubmed | 1.24e-03 | 27 | 67 | 2 | 37995181 | ||
| Pubmed | 1.40e-03 | 250 | 67 | 4 | 33536335 | ||
| Pubmed | 1.52e-03 | 645 | 67 | 6 | 25281560 | ||
| Pubmed | 1.64e-03 | 31 | 67 | 2 | 23322298 | ||
| Pubmed | Role of inflammation gene polymorphisms on pain severity in lung cancer patients. | 1.86e-03 | 33 | 67 | 2 | 19773451 | |
| Pubmed | 1.88e-03 | 126 | 67 | 3 | 16284245 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | NBPF19 NBPF15 NBPF12 NBPF9 NBPF10 PIP5K1A NBPF11 NBPF14 NBPF20 | 7.89e-09 | 404 | 67 | 9 | chr1q21 |
| Cytoband | 1q21.1 | 3.45e-08 | 62 | 67 | 5 | 1q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p11 | 4.33e-04 | 21 | 67 | 2 | chr1p11 | |
| GeneFamily | Neuroblastoma breakpoint family | NBPF8 NBPF19 NBPF15 NBPF12 NBPF9 NBPF10 NBPF26 NBPF11 NBPF14 NBPF20 | 7.11e-21 | 23 | 48 | 10 | 662 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.65e-04 | 57 | 48 | 3 | 1179 | |
| GeneFamily | PRAME family | 1.84e-03 | 24 | 48 | 2 | 686 | |
| GeneFamily | Cyclins|Mediator complex | 3.46e-03 | 33 | 48 | 2 | 1061 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 1.45e-08 | 189 | 67 | 7 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-08 | 198 | 67 | 7 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-08 | 198 | 67 | 7 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-07 | 176 | 67 | 6 | fcf324e6402819683f95e0dd94bf1f777c7f4c76 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.07e-07 | 180 | 67 | 6 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.07e-07 | 180 | 67 | 6 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 3.18e-07 | 181 | 67 | 6 | a62115a8da486fc61225901c72b1ec70bcaf4c36 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.61e-07 | 185 | 67 | 6 | c3d1a312569f3d619f7295812741cbf068ec6c1f | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.09e-07 | 189 | 67 | 6 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-07 | 189 | 67 | 6 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-07 | 190 | 67 | 6 | 7f6dafd5418764d67f6d5ec2153233b791910e81 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 164 | 67 | 5 | 01a7c335897128d3478b8b9b44fb461cab493084 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.68e-06 | 175 | 67 | 5 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-06 | 179 | 67 | 5 | 68ccfe66474d049a926afc21bffa231446becc69 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-06 | 182 | 67 | 5 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 8.52e-06 | 184 | 67 | 5 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 9.95e-06 | 190 | 67 | 5 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 195 | 67 | 5 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-05 | 195 | 67 | 5 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.16e-05 | 196 | 67 | 5 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-05 | 197 | 67 | 5 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 198 | 67 | 5 | 8d1c74a728040386316fbdcabcdea5fb2b5a76a1 | |
| ToppCell | medial-mesenchymal-Vascular_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.24e-05 | 199 | 67 | 5 | 74fe1737a0d63ef0bc49312f1b5823b5c39590dd | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.24e-05 | 199 | 67 | 5 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | medial-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.24e-05 | 199 | 67 | 5 | 8ce0bcc53b3a955285d614459e45210104a6ed02 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.24e-05 | 199 | 67 | 5 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | medial-mesenchymal-Vascular_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.24e-05 | 199 | 67 | 5 | 263603264ff40ea8ef569cb43f8b84b5938438ab | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.24e-05 | 199 | 67 | 5 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.24e-05 | 199 | 67 | 5 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-05 | 200 | 67 | 5 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 200 | 67 | 5 | 3d51aebf626dd4656ab4aac8a20d761b8062c42d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-05 | 200 | 67 | 5 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.60e-05 | 144 | 67 | 4 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | BAL-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 6.77e-05 | 145 | 67 | 4 | 3b2a2965dc18abd39d5ed70c0fcad0210e7f12c8 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-05 | 160 | 67 | 4 | b4844a8c7755a2b2868019791d8d224154973445 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-05 | 160 | 67 | 4 | 01ae730e9d0d05f3277f862f0c09bafb32b89db5 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-05 | 160 | 67 | 4 | 6de9e7be1d860d82d503bfbc779e72f072a6efc3 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 166 | 67 | 4 | 430d604f5bef9fae20dc81492e6695616f6701a3 | |
| ToppCell | Club-club-2|World / Class top | 1.14e-04 | 166 | 67 | 4 | 56f11efb6b686b3ee2c34a051f626e3d761b5112 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.17e-04 | 167 | 67 | 4 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Crh_(Neuron.Gad1Gad2.Sst-Crh)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.29e-04 | 65 | 67 | 3 | d77193259479d0c1667804682dc5b605ebf7119b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Crh_(Neuron.Gad1Gad2.Sst-Crh)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.29e-04 | 65 | 67 | 3 | 443827bb2c469046026ca9b4c52b22bef0681dff | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 1.37e-04 | 174 | 67 | 4 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-04 | 177 | 67 | 4 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 1.46e-04 | 177 | 67 | 4 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 178 | 67 | 4 | 0290868dc990878eac5c182fe64968333bc52450 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 180 | 67 | 4 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 180 | 67 | 4 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 180 | 67 | 4 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-04 | 180 | 67 | 4 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 181 | 67 | 4 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 181 | 67 | 4 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 181 | 67 | 4 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 181 | 67 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | tumor_Lung-Fibroblasts-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 1.59e-04 | 181 | 67 | 4 | 53bcab4d6df4a3255d81877ba22fb95d4492ce9f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 181 | 67 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 182 | 67 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-04 | 183 | 67 | 4 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 183 | 67 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 1.66e-04 | 183 | 67 | 4 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 184 | 67 | 4 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 185 | 67 | 4 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 186 | 67 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 1.77e-04 | 186 | 67 | 4 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-04 | 187 | 67 | 4 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.84e-04 | 188 | 67 | 4 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.92e-04 | 190 | 67 | 4 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 190 | 67 | 4 | 8ceb327dc995f4b83b05d5d6630e1294f0cb49bd | |
| ToppCell | Severe-Lymphoid-NK-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 1.92e-04 | 190 | 67 | 4 | e67803bf55a3f8e47a69ff1829c9100f870d7527 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 1.96e-04 | 191 | 67 | 4 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 1.96e-04 | 191 | 67 | 4 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-04 | 191 | 67 | 4 | 89d03c4133dda852a3713c0902a7d67941cf5b21 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-04 | 191 | 67 | 4 | 47156e5f1d790707f42f6283104a44b33af613e5 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Neutrophil|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.00e-04 | 192 | 67 | 4 | 545c3990cbe3c04bfd95a0ab7499d2c4af509be1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.00e-04 | 192 | 67 | 4 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | moderate-Myeloid-Neutrophil|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.00e-04 | 192 | 67 | 4 | 8105408400dac5dcb0ce62b558433257559c9f09 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.04e-04 | 193 | 67 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 193 | 67 | 4 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 2.04e-04 | 193 | 67 | 4 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 193 | 67 | 4 | c5bd0ed6f57459e54d2463318e8d9b1879718e63 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.04e-04 | 193 | 67 | 4 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | 343B-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 193 | 67 | 4 | 24c06b0461894fe9f68bf26507d7a708468237c2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 193 | 67 | 4 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.08e-04 | 194 | 67 | 4 | 28571cf24b8a1d0ffb716167b977d420868cc874 | |
| ToppCell | 5'|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 194 | 67 | 4 | 7f98f8bfd17a762a2bf748f1c689c7e941793917 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 194 | 67 | 4 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 194 | 67 | 4 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 194 | 67 | 4 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | 356C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-04 | 194 | 67 | 4 | 3f9ac1de8605a7930f49a7ce0e32aea9997d7791 | |
| ToppCell | 21-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 2.08e-04 | 194 | 67 | 4 | 749dd8113ef260e00facac09de9861d61725124a | |
| ToppCell | 356C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-04 | 194 | 67 | 4 | a41cde3088b43670210daab4f43a24aa83dbd45b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 195 | 67 | 4 | e10b21e4dba4483efc4c82d6e395524246ca14a8 | |
| ToppCell | ASK428|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.12e-04 | 195 | 67 | 4 | 41cbd7ea0bfab2db338b4ba0fc67cb3ae0d63d6d | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-04 | 195 | 67 | 4 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.12e-04 | 195 | 67 | 4 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 343B-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-04 | 195 | 67 | 4 | ff87a33f9a48765bfa9408f686985feefeff2adf | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 2.12e-04 | 195 | 67 | 4 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-04 | 195 | 67 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.12e-04 | 195 | 67 | 4 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 195 | 67 | 4 | 9ab3c5b0fb12d406408122a535b717bfe184bbcf | |
| Drug | Pesticides | 3.21e-10 | 150 | 63 | 9 | ctd:D010575 | |
| Disease | cerebral amyloid angiopathy (is_marker_for) | 2.04e-05 | 4 | 55 | 2 | DOID:9246 (is_marker_for) | |
| Disease | Crohn's disease (biomarker_via_orthology) | 2.04e-05 | 4 | 55 | 2 | DOID:8778 (biomarker_via_orthology) | |
| Disease | Paratuberculosis | 5.09e-05 | 6 | 55 | 2 | C0030524 | |
| Disease | Chronic Kidney Diseases | 1.52e-04 | 10 | 55 | 2 | C1561643 | |
| Disease | granulosa cell tumor (is_marker_for) | 1.86e-04 | 11 | 55 | 2 | DOID:2999 (is_marker_for) | |
| Disease | creatinine measurement | 4.85e-04 | 995 | 55 | 8 | EFO_0004518 | |
| Disease | orofacial cleft, sex interaction measurement | 5.62e-04 | 86 | 55 | 3 | EFO_0008343, MONDO_0000358 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 5.72e-04 | 19 | 55 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | Intrahepatic Cholangiocarcinoma | 9.17e-04 | 24 | 55 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 9.17e-04 | 24 | 55 | 2 | C3805278 | |
| Disease | response to venlafaxine | 9.96e-04 | 25 | 55 | 2 | EFO_0006328 | |
| Disease | Cholangiocarcinoma | 1.08e-03 | 26 | 55 | 2 | C0206698 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.25e-03 | 28 | 55 | 2 | DOID:8634 (is_marker_for) | |
| Disease | osteoarthritis (is_implicated_in) | 1.25e-03 | 28 | 55 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | complement factor H-related protein 2 measurement | 1.34e-03 | 29 | 55 | 2 | EFO_0600055 | |
| Disease | Diabetes Mellitus | 1.63e-03 | 32 | 55 | 2 | C0011849 | |
| Disease | colorectal adenoma | 1.74e-03 | 33 | 55 | 2 | EFO_0005406 | |
| Disease | Complement deficiency disease | 1.74e-03 | 33 | 55 | 2 | C0272242 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.77e-03 | 128 | 55 | 3 | DOID:4450 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTYYCRAPTRLDPEN | 221 | Q4AC99 | |
| IRYSAPYCSLPRAPL | 2461 | Q7Z408 | |
| LPDCYSTTPGGTLYA | 16 | O60516 | |
| RLTEYVPSLTERPCY | 91 | Q53H64 | |
| GLCYLQSPDLSPRYL | 191 | A6NFU0 | |
| SPPYCCVDLYSLRTG | 161 | Q9H6U6 | |
| SSLEYPRSYPPDLRC | 206 | P00736 | |
| LSRYLPSYDCLLDDP | 446 | Q8WXS8 | |
| TPLTRGVDCPYLATY | 396 | Q16853 | |
| YGQDSPSCYIPLRRL | 61 | Q96L73 | |
| SGYISLLLRAEPYPT | 186 | P10589 | |
| NDTYRTDLCLLYPPF | 181 | P24863 | |
| SEDPSCPNERYLLYR | 256 | Q4KMQ2 | |
| SAPTGDRCARYPKLY | 1351 | Q9NRD9 | |
| SACYLGTPRSPDYIL | 46 | Q5T3U5 | |
| KSSSYCEYLRPPIDC | 1216 | Q8IY17 | |
| RYACSPLPSYLEGSG | 1461 | P52948 | |
| ELAALCPTTLAPYYL | 41 | O14558 | |
| PRASGSPDYYLRLCL | 131 | Q6ZVW7 | |
| LRYADICPEPSPYSI | 931 | Q96H55 | |
| QYSFPPDYLLCLSRL | 181 | Q8N158 | |
| EYECRPGYRREPSLS | 126 | P08174 | |
| PTDYTLSKCYLPRED | 341 | Q53F39 | |
| CTVTYLPTLPGDYSI | 1876 | O75369 | |
| PKCSSLYEERYVLPS | 1361 | Q9Y4D7 | |
| ARTCIGTPYYLSPEI | 161 | Q6P3R8 | |
| PLCPAADSRTYYSLD | 811 | O14511 | |
| QPRLGLPSRDYYECT | 221 | P08473 | |
| ASCLPDGTALEPEYY | 286 | P42356 | |
| LSYYTRALPPVPDDC | 131 | P35354 | |
| LTAFYPGYLCSLSPE | 441 | Q13421 | |
| EARACPYYGSRLAIP | 346 | Q96FC9 | |
| IRPDDYLYSLCSEPL | 156 | Q99755 | |
| SSCPLIYLDGYTSPG | 2506 | Q99715 | |
| LSYYRAALDPPSSAC | 311 | P29322 | |
| CVAYPEPLGERLYTE | 46 | Q13617 | |
| LSYIPSTFPPLRYLC | 231 | Q3LI83 | |
| YLAEKFTPRSPCGLY | 156 | Q1HG43 | |
| SKELTPTSPDCLRYY | 211 | Q7Z3Z3 | |
| CSLGVYPSYPDLVID | 6 | Q68D06 | |
| PSGICLSYLLSGYTP | 26 | Q9UJX0 | |
| TPCIPYLGIYLSDLT | 196 | Q86X27 | |
| LPTLICDIAGYYPLD | 316 | Q9BX59 | |
| CIETPYSPGSRVILY | 21 | Q969N4 | |
| LDRCYSTPSGYLELP | 676 | Q3BBV2 | |
| DRCYSTPSGYLELPD | 881 | P0DPF3 | |
| LDRCYSTPSGYLELP | 711 | Q6P3W6 | |
| DRCYSTPSGYLELPD | 956 | Q6P3W6 | |
| RCYSTPSGYLELPDL | 1201 | Q6P3W6 | |
| CYSTPSGYLELPDLG | 1446 | Q6P3W6 | |
| LDRCYSTPSGYLELP | 1931 | Q6P3W6 | |
| DRCYSTPSGYLELPD | 2176 | Q6P3W6 | |
| RCYSTPSGYLELPDL | 2421 | Q6P3W6 | |
| CYSTPSGYLELPDLG | 2666 | Q6P3W6 | |
| LDRCYSTPSGYLELP | 3151 | Q6P3W6 | |
| DRCYSTPSGYLELPD | 3396 | Q6P3W6 | |
| RCYSTPSGYLELPDL | 3641 | Q6P3W6 | |
| LDRCYSTPSGYLELP | 711 | Q86T75 | |
| LDRCYSTPSGYLELP | 1226 | Q5TAG4 | |
| LGRCYSTPSGYLELP | 371 | Q5TI25 | |
| GRCYSTPSGYLELPD | 691 | Q5TI25 | |
| DRCYSTPSDYLELPD | 441 | Q8N660 | |
| DRCYSIPSGYLELPD | 441 | A0A087WUL8 | |
| RCYSIPSGYLELPDL | 686 | A0A087WUL8 | |
| CYSIPSGYLELPDLG | 931 | A0A087WUL8 | |
| LDRCYSIPSGYLELP | 1416 | A0A087WUL8 | |
| DRCYSIPSGYLELPD | 1661 | A0A087WUL8 | |
| RCYSTPSGYLELPDL | 1906 | A0A087WUL8 | |
| CYSTPSGYLELPDLG | 2151 | A0A087WUL8 | |
| LDRCYSTPSGYLELP | 2636 | A0A087WUL8 | |
| DRCYSTPSGYLELPD | 2881 | A0A087WUL8 | |
| QDPLDRCYSTPSGYL | 3121 | A0A087WUL8 | |
| RCYSTPSGYLELPDL | 3126 | A0A087WUL8 | |
| DPLDRCYSTPSGYLE | 3366 | A0A087WUL8 | |
| CYSTPSGYLELPDLG | 3371 | A0A087WUL8 | |
| PLDRCYSTPSGYLEL | 3611 | A0A087WUL8 | |
| LDRCYSTPSGYLELP | 96 | P0DPF2 | |
| DRCYSTPSGYLELPD | 341 | P0DPF2 | |
| RCYSTPSGYLELPDL | 586 | P0DPF2 | |
| CYSTPSGYLELPDLG | 831 | P0DPF2 | |
| LDRCYSTPSGYLELP | 1316 | P0DPF2 | |
| DRCYSTPSGYLELPD | 1561 | P0DPF2 | |
| RCYSTPSGYLELPDL | 1806 | P0DPF2 | |
| CYSTPSGYLELPDLG | 2051 | P0DPF2 | |
| LDRCYSTPSGYLELP | 2536 | P0DPF2 | |
| DRCYSTPSGYLELPD | 2781 | P0DPF2 | |
| RCYSTPSGYLELPDL | 3026 | P0DPF2 | |
| CYSTPSGYLELPDLG | 3271 | P0DPF2 | |
| LDRCYSTPSGYLELP | 3756 | P0DPF2 | |
| DRCYSTPSGYLELPD | 4001 | P0DPF2 | |
| RCYSTPSGYLELPDL | 4246 | P0DPF2 | |
| CYSTPSGYLELPDLG | 4416 | P0DPF2 | |
| LDRCYSTPSGYLELP | 4976 | P0DPF2 | |
| LGRCYSTPSGYLELP | 671 | B4DH59 | |
| RPDDYLYSLCNEPLI | 151 | O60331 | |
| NLCLELYPAPRESYD | 406 | Q5VT98 | |
| CLELYPAPRESYGAD | 411 | A6NGN4 | |
| LCILSYPTPLYFGTR | 416 | Q8NG04 | |
| CRYDLGPYLASLPLD | 1456 | Q9UHV7 | |
| ADTDLYTCRPAYTPK | 291 | Q8TEV9 | |
| SYTLLKTCPERPEYL | 736 | O75443 | |
| GLLDPLPFYESCYLD | 1706 | O75443 | |
| YSPYLLAGSSPECDA | 256 | Q32MQ0 | |
| LCYYLSPPESFGSVL | 341 | P61619 | |
| YCGYSTLLIARALPP | 141 | Q8WZ04 | |
| LAEYLSYDSSDPCPG | 441 | Q9Y5Y6 | |
| YPYPSCTETADRELL | 481 | Q8TDW4 | |
| PYAPEPGSTCRLREY | 31 | P20333 | |
| PHRSYSECYPVLLDG | 546 | Q9H9Y6 |